Profilo
Stuart Chaffee is an Independent Director at ABG Acquisition Corp.
I.
He was previously the Chief Financial Officer at Praxis Precision Medicines, Inc. in 2020 and the Head of Business Operations at Kymera Therapeutics, Inc. from 2016 to 2017.
Dr. Chaffee holds an MBA from The Wharton School of the University of Pennsylvania.
Posizioni attive di Stuart Chaffee
| Società | Posizione | Inizio |
|---|---|---|
| ABG ACQUISITION CORP. I | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Stuart Chaffee
| Società | Posizione | Fine |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Direttore Finanziario/CFO | 02/12/2020 |
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2017 |
Formazione di Stuart Chaffee
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
ABG Acquisition Corp. I
ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
















